Author: M. Boulton, Andrew J.

Source: Immunology Endocrine & Metabolic Agents - Medicinal Chemistry (Formerly Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents), Volume 7, Number 1, February 2007 , pp. 79-86(8)

Publisher: Bentham Science Publishers

Abstract:

Diabetic peripheral neuropathy affects up to 50% of older type 2 diabetic patients: at any time, up to 50% of patients will experience painful or uncomfortable symptoms, some of whom will require symptomatic therapy. The first step in management is to exclude other causes of neuropathy and assess the level of glycaemic control. Recent research suggests that neuropathic pain may be exacerbated by erratic blood glucose control: thus the first aim in management should be to optimize and stabilize glycaemic control. A number of symptomatic therapies have been proven to be efficacious in randomized controlled trials. Whereas the tricyclic drugs are still commonly prescribed, their use is limited by troublesome and predictable side effects. The anticonvulsants Gabapentin and Pregabalin are now widely used in the management of neuropathic pain: the adverse events appear to be superior to the tricyclics. Other promising therapies include Duloxetine and Tramadol. There is also increasing evidence that opioids may be efficacious in some severe cases unresponsive to traditional treatments.

Keywords: Diabetic neuropathy; pain; glycaemic control; therapies

Document Type: Research article

DOI: http://dx.doi.org/10.2174/187152207779802446

Affiliations: 1: Manchester Royal Infirmary,Department of Medicine, Manchester, M13 9WL, UK.

Publication date: 2007-02-01

More about this publication?

• Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in the medicinal chemistry and rational drug design for the discovery of new Immunology, Endocrine & Metabolic Agents. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in Immunology, Endocrine & Metabolic medicinal chemistry.
  
  Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in Immunology, Endocrine & Metabolic drug discovery.

Related content

• In this: publication
• By this: publisher
• In this Subject: Chemistry ,  Allergy & Immunology ,  Pharmacology
• By this author: M. Boulton, Andrew J.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers